Oral Arginine as Adjuvant for Vaso-Occlusive Crisis Management Oral Arginine as Adjuvant for Vaso-Occlusive Crisis Management

Oral arginine supplementation significantly increased plasma arginine levels and improved acute pain-related outcomes in children with sickle cell disease in a randomized, placebo-controlled, phase 2 trial.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pediatrics News Source Type: news